Song Lizhi, a vaccine bid evaluation official at the Shandong Provincial Center for Di

According to the China Times, Song Lizhi, director of the Immunization Institute of the Shandong Provincial Center for Disease Control and Prevention, tried to commit suicide by injecting excess insulin. He is currently being rescued in the ICU ward of Shandong Provincial Hospital and is not out of danger.

According to the report, the newspaper verified the authenticity of the above news through multiple independent sources.

It is understood that Song Lizhi is one of the five members of the bid evaluation committee for Changsheng Biotech's winning bid for the DPT vaccine.

In May of this year, Song Lizhi accepted an exclusive interview with a Shandong health reporter. The title of the article was "How does Shandong cope with the troubled times of vaccines?" Song Lizhi, director of the Immunization Prevention Management Institute of the Shandong Provincial Center for Disease Control and Prevention, answered the reporter's question.

Recently, there has been a lot of public opinion triggered by the Changchun Changsheng unqualified vaccine case. As the only province where 250,000 unqualified vaccines have flowed into the province, the Shandong Provincial Center for Disease Control and Prevention has been criticized by public opinion.

The Shandong Provincial Center for Disease Control and Prevention announced in the early morning of July 23 that as early as November 2017, the former State Food and Drug Administration announced that Changchun Changsheng’s DPT vaccine had unqualified potency, and Shandong Province had stopped vaccination for the first time., and found out the flow, inventory, vaccinated children and vaccination status of the relevant batch of vaccines within three days, sealed up the batch of unused vaccines, and carried out risk assessment work at the same time.

A widely circulated internal document shows that as early as October 31, 2017, the Food and Drug Administration of Shandong Province issued a notice on the disposal of unqualified DPT vaccines.The food and drug administrations of all cities are requested to actively cooperate in the recall and disposal of unqualified vaccines, and at the same time strengthen public opinion monitoring and prepare for communication and explanation.the document reads.And the document has not been made public.

According to the official disclosure later, 252,600 unqualified DPT vaccines (batch number 201605014-01) produced by Changchun Changsheng Company flowed into Shandong and flowed to 8 cities including Jinan, Zibo, Yantai, Jining, Taian, Weihai, Rizhao, and Laiwu..247,359 of these vaccines have been vaccinated, and 5,241 were lost or sealed, involving 215,184 children.

The report pointed out that since the flow of unqualified vaccines has been investigated, why has it not organized replanting work in the past nine months, and has not notified the society of unqualified vaccines? Whether there is malfeasance in the Shandong Provincial Center for Disease Control and Prevention has become a public questionFocus.

As a buyer of vaccines, we will strictly inspect the batches and issue certificates of conformity before receiving the goods, but we do not have the responsibility and ability to test the safety and effectiveness of vaccines.On the evening of July 28, the Shandong Provincial Center for Disease Control and Prevention issued a statement on the WeChat public account. However, instead of being understood, this statement once again aroused public anger.Get rid of the public's accusation of its regulatory negligence.

On the 31st, the reporter called Song Lizhi's mobile phone many times, but no one answered the phone.I haven't heard anything about it.Hou Jiaxiang, director of the Shandong Provincial Center for Disease Control and Prevention Office, said in an interview that he would verify the relevant information, but as of press time, he had not received a reply. FDA: Wuhan biological problem vaccine is accidental due to equipment failure

The spokesperson of the State Food and Drug Administration of China today (31st) introduced the relevant situation of the DPT vaccine of Wuhan Institute of Biological Products Co., Ltd.The reason is that the short-term failure of the dispensing equipment is sporadic.

According to the website of the State Food and Drug Administration of China, regarding how to discover the unqualified potency index of the Wuhan DPT vaccine, the spokesperson said that in 2017, the former China Food and Drug Administration of the StateDuring the sampling inspection, it was found that the pertussis potency index of the diphtheria vaccine produced by Wuhan Biology with the batch number 201607050-2 did not meet the standard requirements, and the diphtheria and tetanus potency indexes met the regulations.Relevant information was announced to the public on November 3, 2017.After on-site inspection and retrospective analysis of the company, the main reason for the unqualified potency of this batch of vaccines in Wuhan Biotech was the short-term failure of the packaging equipment, which resulted in uneven suspension of the product to be packaged, which was accidental.

The spokesperson said that after the potency was found to be unqualified, the former State Food and Drug Administration immediately dispatched an inspection team to conduct a comprehensive on-site inspection of the company, and worked with the former National Health and Family Planning Commission to arrange for the disposal of unqualified DPT vaccines.The supervision and management bureau entered Wuhan Biology, and the company sealed up and recalled unqualified vaccines in a timely manner.After investigation, Wuhan Biology produced a total of 400,520 vaccines with unqualified potency in the 201607050-2 batch in 2016, sold 190,520 to the Chongqing Center for Disease Control and Prevention, and 210,000 to the Hebei Provincial Center for Disease Control and Prevention.The company recalled all unused vaccines and destroyed them under the supervision of Wuhan Food and Drug Administration on May 4, 2018.In accordance with the requirements of the former State Food and Drug Administration, the Hubei Provincial Food and Drug Administration supervised the company's rectification, and Wuhan Biotech strengthened the maintenance of key process equipment to ensure the normal operation of the equipment, revised the sub-packaging procedures, and strengthened the quality control of the sub-packaging process.Strengthen personnel training, improve personnel quality awareness, and ensure the effective operation of the quality management system.

The China Food and Drug Control Institute conducted sampling inspections on other batches of DPT vaccines within the validity period of the company, and the inspection results met the regulations.In the subsequent batch release work, the potency of 30 batches of DPT vaccines produced continuously by the company was tested, and the results all met the regulations.In March 2018, the former State Food and Drug Administration dispatched an inspection team again to inspect the rectification of Wuhan Biological DPT vaccine. The company has completed the rectification and complies with the Good Manufacturing Practice (GMP).

As for related punishment issues, the spokesperson said that the former State Food and Drug Administration required local food and drug supervision and management departments to punish Wuhan Biology in accordance with regulations and procedures.On May 29, 2018, the Wuhan Municipal Food and Drug Administration made an administrative penalty decision on confiscating illegal income and fines against Wuhan Biology in accordance with the relevant laws and regulations of the Drug Administration Law.